Market Overview:
The global skin biopsy market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of skin cancer, rising awareness about early diagnosis and treatment of skin diseases, and technological advancements in the field of dermatology. The global skin biopsy market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into shave biopsy, excisional biopsy, incisional biopsy. On the basis of application, it is divided into hospital use (including pathology labs), clinic use (including dermatologists’ offices), research center use (including academic institutions), and other applications such as forensic pathology laboratories).
Product Definition:
A skin biopsy is the removal of a small piece of skin for examination under a microscope. It is often used to diagnose skin conditions, such as cancer.
Shave Biopsy:
Shave biopsy is a minimally invasive procedure used to obtain tissue or fluid from the shave area for examination under a microscope. It is mainly used in dermatology but also finds its usage in other fields like pathology, histology and cytology among others. The procedure has certain advantages over skin biopsy which includes it's easier, faster and less painful among others. This leads to an increase in demand of the procedure leading to market growth of shave biopsy market globally.
Excisional Biopsy:
Excisional biopsy is a diagnostic procedure used for the removal of tissue from an area of skin. It's major use is in diagnosis of skin cancer and lesions. The device basically consists of a hollow tube which is inserted into the skin and then attached to a vacuum cleaner like device, this extracts the tissue from inside out which helps in easy identification & removal of abnormal tissues or lesions present inside the body.
Application Insights:
Skin biopsy is used for various applications including hospital use, clinic use, research center and others. Hospital-based skin biopsies are most commonly performed in the diagnosis of cutaneous T-cell lymphoma (CTCL) as well as other skin tumors. Clinic-based skin biopsies are mostly performed to investigate suspicious lesions that may require a tissue sample for histopathological examination.
Other application segments include dermatology pathology laboratories where these procedures are used for routine pathological analysis of dermal tumor samples from patients suffering from chronic non-melanoma or melanoma skin cancer at a global level.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of skin cancer and other disorders, availability of technologically advanced devices, and presence of well-established healthcare facilities in this region. Moreover, increasing government initiatives for early diagnosis is expected to fuel regional growth during the forecast period. For instance, as part of its ongoing efforts to create awareness about skin cancer and facilitate access to treatment for all Americans free of charge, Medicines360x has organized a campaign called “Free Cancer Care†which began on 1 October 2018 until 31 October 2018 offering free shave biopsy services at participating centers throughout the U.S., including sites located at Los Angeles; Miami; New York City; Chicago; Dallas/Fort Worth Area (Texas); San Francisco Bay Area (California); Seattle/Puget Sound Area (Washington State) along with many more locations across Canada & Mexico [1].
Growth Factors:
- Increasing incidence of skin diseases: The global incidence of skin diseases is increasing rapidly. This is mainly due to the changing lifestyles and environmental conditions. This is expected to drive the demand for skin biopsy procedures in the coming years.
- Growing awareness about early diagnosis and treatment: There is a growing awareness among people about the importance of early diagnosis and treatment of skin diseases. This is likely to boost the demand for skin biopsy procedures in the near future.
- Rising popularity of minimally invasive techniques: Minimally invasive techniques are becoming increasingly popular due to their advantages over traditional surgical procedures, such as shorter recovery time and reduced pain and scarring. This is likely to fuel the growth of the global Skin Biopsy market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Skin Biopsy Market Research Report
By Type
Shave Biopsy, Excisional Biopsy, Incisional Biopsy
By Application
Hospital Use, Clinic Use, Research Center, Other
By Companies
Boston Scientific Corporation (US), COOK Medical (US), BD (US), DTR Medical Ltd (U.K), Devicor Medical Products, Inc., Leica Biosystems. (US), Gallini Srl (Italy), Hologic(US), Cardinal Health (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
178
Number of Tables & Figures
125
Customization Available
Yes, the report can be customized as per your need.
Global Skin Biopsy Market Report Segments:
The global Skin Biopsy market is segmented on the basis of:
Types
Shave Biopsy, Excisional Biopsy, Incisional Biopsy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Use, Clinic Use, Research Center, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific Corporation (US)
- COOK Medical (US)
- BD (US)
- DTR Medical Ltd (U.K)
- Devicor Medical Products, Inc.
- Leica Biosystems. (US)
- Gallini Srl (Italy)
- Hologic(US)
- Cardinal Health (US)
Highlights of The Skin Biopsy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Shave Biopsy
- Excisional Biopsy
- Incisional Biopsy
- By Application:
- Hospital Use
- Clinic Use
- Research Center
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Skin Biopsy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Skin biopsy is a procedure that involves taking a small piece of skin from the patient's body to examine for signs of cancer.
Some of the major companies in the skin biopsy market are Boston Scientific Corporation (US), COOK Medical (US), BD (US), DTR Medical Ltd (U.K), Devicor Medical Products, Inc., Leica Biosystems. (US), Gallini Srl (Italy), Hologic(US), Cardinal Health (US).
The skin biopsy market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Skin Biopsy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Skin Biopsy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Skin Biopsy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Skin Biopsy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Skin Biopsy Market Size & Forecast, 2018-2028
4.5.1 Skin Biopsy Market Size and Y-o-Y Growth
4.5.2 Skin Biopsy Market Absolute $ Opportunity
Chapter 5 Global Skin Biopsy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Skin Biopsy Market Size Forecast by Type
5.2.1 Shave Biopsy
5.2.2 Excisional Biopsy
5.2.3 Incisional Biopsy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Skin Biopsy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Skin Biopsy Market Size Forecast by Applications
6.2.1 Hospital Use
6.2.2 Clinic Use
6.2.3 Research Center
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Skin Biopsy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Skin Biopsy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Skin Biopsy Analysis and Forecast
9.1 Introduction
9.2 North America Skin Biopsy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Skin Biopsy Market Size Forecast by Type
9.6.1 Shave Biopsy
9.6.2 Excisional Biopsy
9.6.3 Incisional Biopsy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Skin Biopsy Market Size Forecast by Applications
9.10.1 Hospital Use
9.10.2 Clinic Use
9.10.3 Research Center
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Skin Biopsy Analysis and Forecast
10.1 Introduction
10.2 Europe Skin Biopsy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Skin Biopsy Market Size Forecast by Type
10.6.1 Shave Biopsy
10.6.2 Excisional Biopsy
10.6.3 Incisional Biopsy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Skin Biopsy Market Size Forecast by Applications
10.10.1 Hospital Use
10.10.2 Clinic Use
10.10.3 Research Center
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Skin Biopsy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Skin Biopsy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Skin Biopsy Market Size Forecast by Type
11.6.1 Shave Biopsy
11.6.2 Excisional Biopsy
11.6.3 Incisional Biopsy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Skin Biopsy Market Size Forecast by Applications
11.10.1 Hospital Use
11.10.2 Clinic Use
11.10.3 Research Center
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Skin Biopsy Analysis and Forecast
12.1 Introduction
12.2 Latin America Skin Biopsy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Skin Biopsy Market Size Forecast by Type
12.6.1 Shave Biopsy
12.6.2 Excisional Biopsy
12.6.3 Incisional Biopsy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Skin Biopsy Market Size Forecast by Applications
12.10.1 Hospital Use
12.10.2 Clinic Use
12.10.3 Research Center
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Skin Biopsy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Skin Biopsy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Skin Biopsy Market Size Forecast by Type
13.6.1 Shave Biopsy
13.6.2 Excisional Biopsy
13.6.3 Incisional Biopsy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Skin Biopsy Market Size Forecast by Applications
13.10.1 Hospital Use
13.10.2 Clinic Use
13.10.3 Research Center
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Skin Biopsy Market: Competitive Dashboard
14.2 Global Skin Biopsy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific Corporation (US)
14.3.2 COOK Medical (US)
14.3.3 BD (US)
14.3.4 DTR Medical Ltd (U.K)
14.3.5 Devicor Medical Products, Inc.
14.3.6 Leica Biosystems. (US)
14.3.7 Gallini Srl (Italy)
14.3.8 Hologic(US)
14.3.9 Cardinal Health (US)
